These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38515359)

  • 21. Factors associated with caregiver burden in patients with Alzheimer's disease.
    Kang HS; Myung W; Na DL; Kim SY; Lee JH; Han SH; Choi SH; Kim S; Kim S; Kim DK
    Psychiatry Investig; 2014 Apr; 11(2):152-9. PubMed ID: 24843370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Differential Rates of Disease Progression in Amyloid-Positive Early Alzheimer's Disease: Findings from a Longitudinal Cohort Analysis.
    Chandler J; Georgieva M; Desai U; Done N; Gomez-Lievano A; Ye W; Zhao A; Eid D; Hilts A; Kirson N; Schilling T
    J Prev Alzheimers Dis; 2024; 11(2):320-328. PubMed ID: 38374738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term progression of Alzheimer's disease in patients under antidementia drugs.
    Gillette-Guyonnet S; Andrieu S; Nourhashemi F; Gardette V; Coley N; Cantet C; Gauthier S; Ousset PJ; Vellas B;
    Alzheimers Dement; 2011 Nov; 7(6):579-92. PubMed ID: 22055975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
    Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropsychiatric Inventory-Assessed Nighttime Behavior Accompanies, but Does Not Precede, Progressive Cognitive Decline Independent of Alzheimer's Disease Histopathology.
    Atayde AL; Fischer CE; Schweizer TA; Munoz DG
    J Alzheimers Dis; 2020; 74(3):839-850. PubMed ID: 32116249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Donanemab in Early Alzheimer's Disease.
    Mintun MA; Lo AC; Duggan Evans C; Wessels AM; Ardayfio PA; Andersen SW; Shcherbinin S; Sparks J; Sims JR; Brys M; Apostolova LG; Salloway SP; Skovronsky DM
    N Engl J Med; 2021 May; 384(18):1691-1704. PubMed ID: 33720637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropsychiatric symptoms and functional status in Alzheimer's disease and vascular dementia patients.
    D'Onofrio G; Sancarlo D; Panza F; Copetti M; Cascavilla L; Paris F; Seripa D; Matera MG; Solfrizzi V; Pellegrini F; Pilotto A
    Curr Alzheimer Res; 2012 Jul; 9(6):759-71. PubMed ID: 22715983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trajectories and risk factors of dementia progression: a memory clinic cohort followed up to 3 years from diagnosis.
    Edwin TH; Strand BH; Persson K; Engedal K; Selbæk G; Knapskog AB
    Int Psychogeriatr; 2021 Aug; 33(8):779-789. PubMed ID: 33213607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychometric Properties of the Clinical Dementia Rating Scale Sum of Boxes in Parkinson's Disease.
    Gallagher J; Rick J; Xie SX; Martinez-Martin P; Mamikonyan E; Chen-Plotkin A; Dahodwala N; Morley J; Duda JE; Trojanowski JQ; Siderowf A; Weintraub D
    J Parkinsons Dis; 2021; 11(2):737-745. PubMed ID: 33386814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sum of boxes of the clinical dementia rating scale highly predicts conversion or reversion in predementia stages.
    Tzeng RC; Yang YW; Hsu KC; Chang HT; Chiu PY
    Front Aging Neurosci; 2022; 14():1021792. PubMed ID: 36212036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stages of Objective Memory Impairment Predict Alzheimer's Disease Neuropathology: Comparison with the Clinical Dementia Rating Scale-Sum of Boxes.
    Grober E; Qi Q; Kuo L; Hassenstab J; Perrin RJ; Lipton RB
    J Alzheimers Dis; 2021; 80(1):185-195. PubMed ID: 33492286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of metrifonate on the cognitive, behavioral, and functional performance of Alzheimer's disease patients. Metrifonate Study Group.
    Raskind MA; Cyrus PA; Ruzicka BB; Gulanski BI
    J Clin Psychiatry; 1999 May; 60(5):318-25. PubMed ID: 10362441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropsychiatric symptoms in Alzheimer's disease: associations with caregiver burden and treatment outcomes.
    Chen CT; Chang CC; Chang WN; Tsai NW; Huang CC; Chang YT; Wang HC; Kung CT; Su YJ; Lin WC; Cheng BC; Su CM; Hsiao SY; Hsu CW; Lu CH
    QJM; 2017 Sep; 110(9):565-570. PubMed ID: 28383687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired Cognitive Function is Associated with Motor Function and Activities of Daily Living in Mild to Moderate Alzheimer's Dementia.
    Lee G
    Curr Alzheimer Res; 2020; 17(7):680-686. PubMed ID: 32811414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rivastigmine for Alzheimer's disease.
    Birks JS; Grimley Evans J
    Cochrane Database Syst Rev; 2015 Apr; (4):CD001191. PubMed ID: 25858345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparing measures of decline to dementia in amnestic MCI subjects in the National Alzheimer's Coordinating Center (NACC) Uniform Data Set.
    Monsell SE; Liu D; Weintraub S; Kukull WA
    Int Psychogeriatr; 2012 Oct; 24(10):1553-60. PubMed ID: 22717299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential Implications of Slowing Disease Progression in Amyloid-Positive Early Alzheimer's Disease: Estimates from Real-World Data.
    Chandler J; Done N; Desai U; Georgieva M; Gomez-Lievano A; Ye W; Zhao A; Eid D; Hilts A; Kirson N; Schilling T
    J Prev Alzheimers Dis; 2024; 11(2):310-319. PubMed ID: 38374737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study.
    Kahle-Wrobleski K; Andrews JS; Belger M; Ye W; Gauthier S; Rentz DM; Galasko D
    J Prev Alzheimers Dis; 2017; 4(2):72-80. PubMed ID: 29186278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of cognitive functions and neuropsychiatric symptoms between patients with Parkinson's disease dementia and Alzheimer's disease].
    Tang Y; Ji XJ; Xing Y; Zuo XM; Zhou AH; Jia JP
    Zhonghua Yi Xue Za Zhi; 2013 Aug; 93(31):2459-62. PubMed ID: 24300264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Vascular Risk Factors on the Progression of Mild Alzheimer's Disease and Lewy Body Dementia.
    Bergland AK; Dalen I; Larsen AI; Aarsland D; Soennesyn H
    J Alzheimers Dis; 2017; 56(2):575-584. PubMed ID: 28035932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.